COEPW (STOCKS)
Coeptis Therapeutics Holdings, Inc. Warrants
—
Change: —
Prev close: —
Company Information
- Exchange
- XNAS
- Sector
- —
- Industry
- —
- CEO
- —
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- —
- Employees
- 7
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $1.36M |
| Benefits Costs and Expenses | $13.64M |
| Cost Of Revenue | $180.63K |
| Costs And Expenses | $13.64M |
| Gross Profit | $1.18M |
| Nonoperating Income/Loss | $766.31K |
| Operating Expenses | $14.23M |
| Research and Development | $1.28M |
| Other Operating Expenses | $12.95M |
| Operating Income/Loss | -$13.04M |
| Income/Loss From Continuing Operations After Tax | -$12.28M |
| Income/Loss From Continuing Operations Before Tax | -$12.28M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$12.28M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$360.18K |
| Net Income/Loss Attributable To Parent | -$11.92M |
| Net Income/Loss Available To Common Stockholders, Basic | -$11.92M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.81 |
| Diluted Earnings Per Share | -$2.81 |
| Basic Average Shares | 4,234,787 |
| Diluted Average Shares | 4,234,787 |
| Assets | $16.15M |
| Current Assets | $7.35M |
| Prepaid Expenses | $991.90K |
| Other Current Assets | $6.36M |
| Noncurrent Assets | $8.80M |
| Fixed Assets | $9.87K |
| Intangible Assets | $361.25K |
| Other Non-current Assets | $8.43M |
| Liabilities | $2.09M |
| Current Liabilities | $1.77M |
| Accounts Payable | $888.76K |
| Other Current Liabilities | $879.38K |
| Noncurrent Liabilities | $317.63K |
| Equity | $14.07M |
| Equity Attributable To Noncontrolling Interest | $506.16K |
| Equity Attributable To Parent | $13.56M |
| Liabilities And Equity | $16.15M |
| Net Cash Flow From Operating Activities | -$8.60M |
| Net Cash Flow From Operating Activities, Continuing | -$8.60M |
| Net Cash Flow From Investing Activities | -$5.14M |
| Net Cash Flow From Investing Activities, Continuing | -$5.14M |
| Net Cash Flow From Financing Activities | $13.74M |
| Net Cash Flow From Financing Activities, Continuing | $13.74M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$12.28M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$12.28M |
| Other Comprehensive Income/Loss | $0.00 |